Mason Michael

Track

Insider profile

Performance

Overall performance
4.0
Performance over holding periods
4.0
30 days 90 days 120 days
Average return 6% 8.2% 15.1%
Success rate 66% 68% 82%
Transactions
27 33% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Mason Michael's trades of Karyopharm Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-05 2024-09-04
S Sale
29,262 +7.1%
128.06
US$3,822,586 		29,262 +7.1% 128.06 US$3,822,586
2024-08-09 2024-08-08
B Purchase
73,762
350.56
£957,843 		73,762 350.56 £957,843
2024-06-06 2024-06-04
S Sale
67,583 -2.1%
259.86
US$595,097 		67,583 -2.1% 259.86 US$595,097
2024-03-19 2024-03-15
B Purchase
5,000
6.10
£30,500 		5,000 6.10 £30,500
2024-03-04 2024-03-01
S Sale
6,162 -1.5%
1.20
US$7,394 		6,162 -1.5% 1.20 US$7,394
2024-03-04 2024-02-29
S Sale
27,687 -6.4%
1.17
US$32,394 		27,687 -6.4% 1.17 US$32,394
2024-02-29 2024-02-27
S Sale
2,545 -1.0%
1.32
US$3,369 		2,545 -1.0% 1.32 US$3,369
2024-02-08 2024-02-06
S Sale
4,205 -1.7%
1.59
US$6,671 		4,205 -1.7% 1.59 US$6,671
2023-09-05 2023-09-01
S Sale
6,913 -2.8%
1.33
US$9,203 		6,913 -2.8% 1.33 US$9,203
2023-06-22 2023-06-16
FR Neolife SA (ALNLF)
B Purchase
160,000
0.11
€18,080 		160,000 0.11 €18,080
2023-06-05 2023-06-02
S Sale
631 -0.3%
2.22
US$1,401 		631 -0.3% 2.22 US$1,401
2023-03-02 2023-03-01
S Sale
11,205 -4.4%
3.03
US$33,942 		11,205 -4.4% 3.03 US$33,942
2023-03-01 2023-02-27
S Sale
2,802 -1.7%
3.04
US$8,509 		2,802 -1.7% 3.04 US$8,509
2023-02-08 2023-02-06
S Sale
4,141 -2.5%
3.40
US$14,079 		4,141 -2.5% 3.40 US$14,079
2022-06-06 2022-06-03
S Sale
3 -0.0%
6.07
US$18 		3 -0.0% 6.07 US$18
2022-06-06 2022-06-03
S Sale
598 -0.4%
6.04
US$3,612 		598 -0.4% 6.04 US$3,612
2022-03-02 2022-02-28
S Sale
2,398 -1.7%
10.24
US$24,550 		2,398 -1.7% 10.24 US$24,550
2022-02-09 2022-02-07
S Sale
3,947 -6.9%
9.86
US$38,925 		3,947 -6.9% 9.86 US$38,925
2021-11-08 2021-11-05
B Purchase
5,000
5.04
£25,200 		5,000 5.04 £25,200
2021-09-28 2021-09-22
GB Hiscox Ltd (HSX)
B Purchase
20
9.29
£186 		20 9.29 £186
2021-02-17 2021-02-11
S Sale
2,858 -35.1%
15.52
US$44,354 		2,858 -35.1% 15.52 US$44,354
2019-09-13 2019-09-11
GB Hiscox Ltd (HSX)
B Purchase
16
15.90
£254 		16 15.90 £254
2019-07-29 2019-07-26
B Purchase
4,000
7.05
£28,200 		4,000 7.05 £28,200
2019-06-18 2019-06-12
GB Hiscox Ltd (HSX)
B Purchase
30
16.43
£493 		30 16.43 £493
2018-09-14 2018-09-11
GB Hiscox Ltd (HSX)
B Purchase
14
16.69
£234 		14 16.69 £234
2018-06-15 2018-06-12
GB Hiscox Ltd (HSX)
B Purchase
27
410.13
£11,074 		27 410.13 £11,074
2018-02-16 2018-02-16
B Purchase
3,800
5.89
£22,363 		3,800 5.89 £22,363
2018-01-17 2018-01-12
FR Neolife SA (ALNLF)
S Sale
50,000
0.45
€22,250 		50,000 0.45 €22,250
2017-10-31 2017-10-05
FR Neolife SA (ALNLF)
S Sale
200,000
0.57
€113,760 		200,000 0.57 €113,760